My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Hercules Capital, Inc. Common Stock
(NY:
HTGC
)
17.27
+0.11 (+0.64%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hercules Capital, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Hercules Capital Announces Date for Release of Third Quarter 2025 Financial Results and Conference Call
October 16, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Gilman Hill Adds $7.9 Million Millrose Stake — Bolstering Dividend Income Strategy
October 15, 2025
Via
The Motley Fool
Fund Buys $7.9 Million in NextEra Energy Stock as Clean Power Growth, Yield Attract Investors
October 15, 2025
Via
The Motley Fool
Topics
Energy
Regulatory Compliance
Earnings Scheduled For July 31, 2025
July 31, 2025
Via
Benzinga
Investment Manager Rebalances, Trims Stake in Hercules Capital
October 12, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Big Money Moves: $4.1 Million of Oracle Shares Dumped by Investment Advisor
October 12, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
3 Value Stocks with Open Questions
October 10, 2025
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few...
Via
StockStory
Why Hercules Capital (HTGC) Shares Are Sliding Today
October 09, 2025
Shares of specialty finance company Hercules Capital (NYSE:HTGC) fell 2.8% in the afternoon session after analyst firm Piper Sandler lowered its price target on the stock. Analyst Crispin Love reduced...
Via
StockStory
Topics
Artificial Intelligence
Q2 Earnings Highs And Lows: Hercules Capital (NYSE:HTGC) Vs The Rest Of The Specialty Finance Stocks
September 30, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at specialty finance stocks, starting with...
Via
StockStory
uniQure Stock Doubles On Promising Data From Huntington's Disease Trial
September 24, 2025
UniQure's AMT-130 gene therapy slowed Huntington's disease progression in a Phase 1/2 trial, supported by new $175 million financing for launch readiness.
Via
Benzinga
uniQure Announces Refinancing of Existing $50 Million Debt and Securing Up to an Additional $125 Million in Non-Dilutive Funding
September 24, 2025
From
uniQure Inc.
Via
GlobeNewswire
Hercules Capital Receives Investment Grade Rating Upgrade to Baa2 With Revised Outlook to Stable From Moody’s Investors Service
September 18, 2025
From
Hercules Capital, Inc.
Via
Business Wire
2 Safe-and-Steady Stocks to Target This Week and 1 We Brush Off
September 03, 2025
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Via
StockStory
3 Small-Cap Stocks We Steer Clear Of
September 01, 2025
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...
Via
StockStory
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
August 28, 2025
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...
Via
StockStory
1 Financials Stock with Promising Prospects and 2 We Ignore
August 20, 2025
Financial firms serve as the backbone of the economy, providing essential services from lending and investment management to risk management and payment processing. But uncertainty about fiscal and...
Via
StockStory
Topics
Credit Cards
Economy
Stocks
Hercules Capital Receives a BBB+ Affirmed Investment Grade Corporate and Credit Rating from Kroll Bond Rating Agency, Inc.
August 19, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing
August 05, 2025
From
Snappt
Via
Business Wire
Hercules Capital Reports Second Quarter 2025 Financial Results
July 31, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2025
July 29, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Hercules Capital’s Wholly-Owned Investment Adviser Launches Fourth Institutional Private Credit Fund
July 28, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Hercules Capital Announces Date for Release of Second Quarter 2025 Financial Results and Conference Call
July 17, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Recent Report Shows That Rep. Virginia Foxx Sold Up to $65K Worth of Energy Transfer Stock
July 04, 2025
Via
Benzinga
Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.
July 01, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
June 30, 2025
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Hercules Capital Closes Upsized Institutional Notes Offering of $350.0 Million 6.000% Unsecured Notes due 2030
June 16, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Hercules Capital Renews and Increases Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million
June 12, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Hercules Capital Prices Upsized Institutional Notes Offering of $350.0 Million 6.000% Notes due 2030
June 11, 2025
From
Hercules Capital, Inc.
Via
Business Wire
Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report
June 03, 2025
Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it faces revenue pressure from Keytruda's looming patent cliff.
Via
Benzinga
Topics
Intellectual Property
Hercules Capital Announces Date of 2025 Annual Meeting of Stockholders
May 08, 2025
From
Hercules Capital, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.